abstract |
Disclosed is a novel benzene compound which has an excellent immunosuppressing activity, an excellent rejection-inhibiting effect and others, and is reduced in adverse side effects including bradycardia. Specifically disclosed is a compound represented by general formula (I), (II-1), (II-2), (III-1), (III-2), (IV-1), (IV-2) or (V). |